Sole/single-source supplier

Hong Kong IPO disclosure precedents · 26 companies, 27 items

Reliance on a sole or single-source supplier for a key input or component, often governed by a long-term framework or supply agreement.

2025-03-13Prospectus
VISEN Pharmaceuticals维升药业02561.HK

Since the Core Product is used exclusively with the auto-injector produced by such marketing authorization holder, we expect to rely on its auto-injector supply before we establish our collaborative local manufacturing capability with local CDMO.

Business · p. 329

The import medical device registration application for the auto-injector was submitted by a third-party marketing authorization holder to the NMPA in June 2023 and has been approved in April 2024, ahead of the expected BLA approval date of the Core Product for PGHD in the second half of 2025.

Business · p. 329
The company's explanation, the adviser's view and the page in the filing: see Matters
2024-12-30Prospectus
Numans Health Food Holdings Company Limited纽曼思健康食品控股有限公司02530.HK

For FY2021, FY2022, FY2023 and 6M2024, our purchases from our five largest suppliers for each year/period during the Track Record Period accounted for approximately 90.7%, 92.7%, 94.3% and 92.4% of our total purchases respectively, and our purchases from our largest supplier for each year/period during the Track Record Period accounted for approximately 56.8%, 42.6%, 49.6% and 48.5% of our total purchases, respectively.

Business · p. 221

The algal oil DHA raw materials of our finished algal oil DHA products were all sourced from DSM Group (including DSM Shanghai) and the probiotics raw materials of our finished probiotics products were all sourced from the Probiotics Raw Material Supplier.

Business · p. 227

Considering the market position of DSM Group and the Probiotics Raw Material Supplier, Frost & Sullivan is of the view that it is an industry norm for brand owner of algal oil DHA products and probiotics products like our Group to have material reliance on the principal raw material suppliers like DSM Group and the Probiotics Raw Material Supplier, and it is not commercially realistic for our Group to diversify our reliance.

Business · p. 227
The company's explanation, the adviser's view and the page in the filing: see Matters
2024-12-30Prospectus
Numans Health Food Holdings Company Limited纽曼思健康食品控股有限公司02530.HK

For FY2021, FY2022, FY2023 and 6M2024, the revenue contribution by sales of our New Zealand DHA Products/U.S. DHA Products in aggregated accounted for approximately 67.8%/25.5% and 61.3%/33.6% of our total revenue, respectively

Business · p. 227

As such, our Directors are of the view that our Group has material reliance on Shanghai Trilives, Confidence Group and the New Zealand Processing Company.

Business · p. 228

As such, our Directors are of the view that our reliance on Shanghai Trilives, Confidence Group and the New Zealand Processing Companies is mutual.

Business · p. 228
The company's explanation, the adviser's view and the page in the filing: see Matters
2024-11-20Prospectus
Hangzhou Jiuyuan Gene Engineering Co., Ltd.杭州九源基因工程股份有限公司02566.HK

During the Track Record Period, the only API we sourced from third party is the fulvestrant API for our product Jifuwei (fulvestrant injection), which we sourced from Hangzhou Heta Pharm & Chem Co., Ltd. (杭州海達醫藥化工有限公司), one of our five largest suppliers in 2023 who is not deemed as one of our competitors in relevant market in China.

Business · p. 349

We believe that the supplies of the fulvestrant API used in our production are ample in the market with multiple suppliers, and that we can seek alternative suppliers as and when appropriate in the market without material limitations. Further, we have the capabilities to produce fulvestrant API in-house.

Business · p. 349
The company's explanation, the adviser's view and the page in the filing: see Matters
2024-10-16Prospectus
Horizon Robotics地平线09660.HK

In 2021, 2022 and 2023 and for the six months ended June 30, 2024, the aggregate purchase amounts from our five largest suppliers were RMB251.6 million, RMB890.2 million, RMB1,177.9 million and RMB392.4 million, representing 52.0%, 61.8%, 50.2% and 40.8% of our total purchase amount, respectively.

Business · p. 289

We currently depend on Supplier A to manufacture all of our processing hardware.

Business · p. 286

Our Directors are of the view that, after consultation with CIC and enquiries with the Company’s departments that are responsible for suppliers management, our procurement of semiconductors and the outsourcing of manufacturing and assembling services from Supplier A and Supplier C are in line with industry practices.

Business · p. 288
The company's explanation, the adviser's view and the page in the filing: see Matters
2023-12-12Prospectus
Henan Jinyuan Hydrogenated Chemicals Co., Ltd.河南金源氢化化工股份有限公司02502.HK

For FY2020, FY2021, FY2022 and 1H2023, our amount of purchases of crude coking coal gas and Coke Granule Coal Gas from the Jinma Group amounted to RMB248.6 million, RMB192.7 million, RMB395.1 million and RMB200.9 million, respectively, which accounted for 27.8%, 15.3%, 21.6% and 21.1% of our total principal purchases, respectively, during the corresponding years/period.

Business · p. 200

In each year/period during the Track Record Period, purchases from our five largest suppliers in each year/period accounted for 60.7%, 49.3%, 65.6% and 68.6% of our total principal purchases, respectively, while purchases from our largest supplier, the Jinma Group, accounted for 44.2%, 23.6%, 39.6% and 38.0% of our total principal purchases, respectively.

Business · p. 191

Due to Jinma Group’s retirement of two older coking furnaces in December 2020 in response to China’s environmental protection policies, we experienced shortage in the supply of crude coking coal gas in FY2021, which is the principal raw material for coal gas for the production of LNG.

Business · p. 190
The company's explanation, the adviser's view and the page in the filing: see Matters
2023-06-30Prospectus
Star Plus Legend Holdings Limited巨星传奇集团有限公司06683.HK

In each year during the Track Record Period, purchases from our top five suppliers accounted for approximately 75.1%, 73.3%, 58.3% and 47.9% of our total purchase, respectively, and the total purchase from our largest supplier accounted for approximately 26.9%, 48.1%, 31.2% and 23.2% of our total purchase amount in each year during the Track Record Period, respectively.

Business · p. 250

For the year ended December 31, 2019, 2020, 2021 and 2022, our purchases from Hengmei Group amounted to RMB13.9 million, RMB74.4 million, RMB47.1 million and RMB42.3 million, respectively.

Business · p. 255

We consider engaging only one supplier for the production of such products to be appropriate to minimize the risk of leakage of confidential formulae and inconsistent quality of our products in order to maintain our competitive advantages.

Business · p. 257
The company's explanation, the adviser's view and the page in the filing: see Matters

Tell us